Ovarian cancer is the 6th most common cancer in women in the UK, with 7,400 people diagnosed each year. The symptoms of ovarian cancer can be very vague, particularly when the disease is in its early stages.
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.
Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.
The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.
The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland
A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.
NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.
A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.